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Introduction
Many potential therapies for severe and/or chronic wounds fail
as a result of poor vasculature[1]. Hence, strategies to improve
blood vessel supply into a wound bed are thought to promote
wound healing. Transplantations of mesenchymal stem cells
(MSCs) have shown great potential as a therapeutic agent for
the treatment of a range of disorders, including wound
healing, and have become the subject of numerous clinical
trials[2]. However, whilst the safety of MSC transplantation
does not seem to be an issue[3, 4], the effectiveness of such
treatment has exhibited considerable variability. This variation
in effect is problematic when translating preclinical research
into MSC-based clinical therapy.
We recently demonstrated that human MSC-conditioned
medium (MSC-CM) was stimulatory to epidermal and
fibroblast cell adherence and migration[5]. Other reports
suggest that MSC are pro-angiogenic also through their
paracrine activity on endothelial cells[6, 7]. Whilst there are
reports that MSC are capable of endothelial differentiation[8,9],
engraftment into new vasculature is low in vivo[10,11]. Hence,
these and other studies have contributed to recent thought
that the predominant regenerative activity of MSCs is due to
their secretion of factors that stimulate endogenous cells at
wound sites.
In this investigation, we have examined the effects of MSC-
CM on endothelial cells, using the cell line EaHy-926 as a
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Mesenchymal stem cells (MSCs) stimulate angiogenesis within a wound environment and this effect is mediated through
paracrine interactions with the endothelial cells present. Here we report that human MSC-conditioned medium (n=3 donors)
significantly increased EaHy-926 endothelial cell adhesion and cell migration, but that this stimulatory effect was markedly donor-
dependent. MALDI-TOF/TOF mass spectrometry demonstrated that whilst collagen type I and fibronectin were secreted by all of
the MSC cultures, the small leucine rich proteoglycan, decorin was secreted only by the MSC culture that was least effective upon
EaHy-926 cells. These individual extracellular matrix components were then tested as culture substrata. EaHy-926 cell adherence
was greatest on fibronectin-coated surfaces with least adherence on decorin-coated surfaces. Scratch wound assays were used
to examine cell migration. EaHy-926 cell scratch wound closure was quickest on substrates of fibronectin and slowest on decorin.
However, EaHy-926 cell migration was stimulated by the addition of MSC-conditioned medium irrespective of the types of culture
substrates. These data suggest that whilst the MSC secretome may generally be considered angiogenic, the composition of the
secretome is variable and this variation probably contributes to donor-donor differences in activity. Hence, screening and
optimizing MSC secretomes will improve the clinical effectiveness of pro-angiogenic MSC-based therapies.
model system[12]. We report that MSC-CM promotes endothelial
cell adhesion and migration, but that these effects show
considerable donor-donor variability. Further, we have identified
extracellular matrix (ECM) proteins that are secreted by MSCs
using MALDI/TOF-TOF mass spectrometry. We provide data to
suggest that ECM composition plays a major role in the donor-
donor variation we have seen. These findings demonstrate proof
of principle of the need to screen the MSC secretome in order to
optimise the application of MSCs in the clinic.
Methods
Cell culture and mass spectrometry of conditioned medium
EaHy-926 endothelial cells were maintained in DMEM/F12
culture medium (Invitrogen, Paisley, UK) supplemented with
10% (v/v) fetal calf serum (FCS) (Invitrogen) and 1% (v/v)
penicillin and streptomycin (Invitrogen), incubated at 37°C and
in a humidified atmosphere containing 5% (v/v) CO2. Passaging
was performed at ~90% confluence and cells were re-seeded at
1 x 104 cells/cm2. MSCs were isolated from the iliac crest
biopsies of bone marrow donors following ethical approval and
with informed consent, as previously described[13]. The adherent
cell population obtained was consistent with the characteristics
of MSCs laid out by the International Society for Cellular
Therapy (ISCT)[14]. Conditioned medium was generated from
MSC cultures of equal cell number in serum free
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conditions, using DMEM/F12 supplemented with insulin,
transferrin and selenium (Invitrogen). Protein content of MSC
CM was determined by MALDI-TOF/TOF mass spectrometry
as previously described[5].
Characterization of MSC
After three passages in culture, bone marrow derived cells
were assessed by immunoprofiling for CD markers and by
examining their differentiation potential to form osteoblasts,
adipocytes and chondrocytes, by staining with alkaline
phosphatase, oil red O, and toluidine blue respectively as per
the criteria established for a MSC phenotype by the ISCT[14].
Coating of culture plates
Culture plates were coated with MSC-CM or type-I collagen,
decorin, or fibronectin (all Sigma-Aldrich). Protein solutions
were diluted in PBS to 0.2mg/ml and added to each well (50µl
for 96-well plates, 500µl for 24-well plates). These were
refrigerated for 24 hours before being rinsed with PBS
immediately prior to use.
Cell adherence/spreading
Coated 24-well tissue culture plates were seeded with 2x105
EaHy-926 endothelial cells in DMEM/F12 supplemented with
1% penicillin/streptomycin (Sigma-Aldrich) and 1% ITS-X
(Sigma-Aldrich) and incubated for 2 hours at 37°C and 5%
CO2 before digital images were captured (ProgRes CF,
Jenoptik) and analysed using Image-J software.
Scratch-wound assays
Scratch assays were established using previously published
methods[5], in protein-coated tissue culture plates (as
described above).  Cell migration was automatically captured
and analysed at hourly intervals using an IncucyteTM Live-
Cell Imaging System (Essen Bioscience).
Statistical analysis
Data is presented as means (± SEM). Data were tested for
significance using the Mann-Whitney U test. Those
differences that fell within a 95%, 99% or 99.9% confidence
interval were considered to be significant, indicated by
asterisks within Figures (* p<0.05 ** p<0.01 *** p<0.001).
Results
Bone marrow cells obtained from iliac crest biopsies showed
characteristics consistent with those expected of
MSC (Figure 1). MSC-CM coating of culture plates resulted
in the significant enhancement of the spreading of EaHy-926
endothelial cells upon the culture surface. This result was
subject to a marked inter-donor variability, with conditioned
media generated by both MSC-1 and MSC-3 resulting in a
significantly greater degree of EaHy-926 endothelial cell
spreading than that generated by MSC-2 (Figure 2a, 2b).
EaHy-926 endothelial cell adherence on fibronectin coated
plates was most advanced after two hours, compared to
plates coated in either type I collagen or with
decorin (Figure 3). On type I collagen-coated plates, the
presence of MSC-CM appeared to enhance the rate of EaHy-
926 endothelial cell migration into scratch-wounds compared
to unconditioned media (Figure 4a, left). EaHy-926
endothelial cells in MSC-CM closed scratch-wounds to a
significantly greater degree than those in unconditioned
media over a 12-hour time course (Figure 4b, left). Once
again, the degree of this MSC-CM mediated enhancement of
EaHy-926 endothelial cell migration was subject to inter-
donor variability. Conditioned medium generated by MSC-1
(and MSC-3) elicited a greater degree of scratch-wound
closure than MSC-2 over 12 hours (Figure 4b, left).
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Figure 1 Cells isolated from bone marrow meet the minimum criteria for identification as MSC. Cells are immunoreactive for CD73,
CD90 and CD105, whilst lacking immunoreactivity for CD14, CD34 and CD45, as shown by histograms obtained by flow cytometry, and readily
differentiate to form osteoblasts, adipocytes and chondrocytes in vitro. Representative phase contrast images are shown of cells following tri-
lineage differentiation and staining with alkaline phosphotase, oil red O, and toluidine blue (top, left to right). Scale bars = 50µm.
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Figure 2 MSC-CM coating of culture plates influences EaHy-926
endothelial cell adherence and spreading. A: MSC-CM coating of
culture plates influences EaHy-926 endothelial cell adherence and
spreading. After 4 hours in culture EaHy-926 endothelial cells were
observably more spread on culture plates coated with MSC-CM than on
plates coated with unconditioned (control) medium. Representative phase
contrast images are shown of EaHy-926 endothelial cells 4 hours post
seeding. B: After 4 hours in culture the average cell area was significantly
greater for EaHy-926 endothelial cells on MSC-CM coated culture plates
and 389µm2 than those cells on unconditioned (control) medium coated
culture plates. Data shown are means ± SEM in relative units
(***=p<0.001 Mann Whitney U test).
Figure 3 ECM protein coating of culture plates influences EaHy-926
endothelial cells adherence and spreading. After 4 hours in culture EaHy-926
endothelial cells were observably more spread on culture plates coated with
fibronectin than on plates coated with type I collagen or decorin. Representative
phase contrast images are shown of EaHy-926 endothelial 4 hours post seeding.
B: After 4 hours in culture the average cell area was significantly greater for EaHy-
926 endothelial cells on fibronectin compared to those cells on either type I
collagen or decorin. Data shown are means ± SEM in relative units (**=p<0.01,
***=p<0.001, Mann Whitney U test).
Figure 4 EaHy-926 endothelial cells closed scratch wounds
faster in MSC-CM than in unconditioned medium on type I
collagen, fibronectin, and decorin coated culture plates. A:
EaHy-926 cells on fibronectin coated culture plates closed scratch
wounds significantly faster than those on either type I collagen or
decorin. Representative phase contrast images are shown of
EaHy-926 scratch assays 12 hours post scratching. B: After 12
hours EaHy-926 endothelial cells in MSC-CM had closed scratch
wounds by a significantly greater degree than those in
unconditioned control medium. 12 hours post-scratching,
EaHy-926 endothelial cells on plates coated fibronectin had
closed scratch wounds by a significantly greater degree than
those on either type I collagen or decorin. On fibronectin and
decorin, medium conditioned by MSC-2 was associated with
significantly reduced scratch closure compared to either MSC-1 or
MSC-3. On type one collagen, medium conditioned by MSC-2 was
associated with significantly reduced scratch closure compared to
MSC-1. Data shown are means ± SEM. (* = p<0.05 by Mann
Whitney U test).
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These MSC-CM were examined by MALDI/TOF/TOF mass
spectrometry. All three were found to contain fibronectin,
collagen type I, collagen type VI, and lumican, whilst cartilage
oligomeric matrix protein (COMP) and SPARC were present
in two out of three MSC-CM and laminin, decorin, heparan
sulphate proteoglycan (HSPG) and IGFBP-1 were each only
observed in one MSC-CM (Table 1). Of these, decorin, along
with HSPG were only present in medium conditioned using
MSC-2. Hence, not only was there clear inter-donor
variability in the ECM components of the MSC secretome,
but the presence of these proteoglycans seemed to be
associated with a reduction in the efficacy of MSC-CM.
When type I collagen, decorin and fibronectin were used as
culture substrata, the degree of EaHy-926 endothelial cell
spreading appeared to be similar upon both type I collagen
Discussion
We have previously shown that MSC-CM promotes the
migration of skin cells in a wound healing model, and
identified numerous potentially beneficial factors that may
contribute to this effect. In vivo wound healing is, however, a
complex process influenced by a host of cellular events,
including angiogenesis. If MSC can stimulate endothelial
cells as suggested here and elsewhere[7] this supports their
potential use in the treatment of cutaneous wounds.
In these experiments, MSC-CM was found to be stimulatory
to endothelial cell migration in vitro. This is similar to previous
and decorin and greatly enhanced upon fibronectin (Figure
2a, 2b).
Similarly, scratch-wound closure by EaHy-926 endothelial
cells in unconditioned media appeared to be similar upon
type I collagen and decorin, but markedly greater upon
fibronectin (Figure 4a, 4b). In the presence of each ECM
substrate the presence of MSC-CM resulted in significantly
enhanced scratch wound closure compared to unconditioned
media (Figure 4b). As seen previously upon type I collagen
coated culture plates, the degree of closure upon both
decorin and fibronectin coated plates was either significantly
or near significantly (p=0.057 by Mann Whitney U test) less
in the presence of medium conditioned by MSC-2, compared
to medium conditioned by either MSC-1 or MSC-3 (Figure
4b).
studies in which MSC-CM has been shown to stimulate
angiogenesis[7], supporting the investigation of MSC-CM as a
pro-angiogenic agent. Although it is possible for proliferation
of EaHy-926 endothelial cells to have contributed somewhat
to the closure of the scratch wounds, these scratch assay
experiments were performed over the course of 12 hours.
The reported doubling time for these cells is over
25 hours[15]. To significantly affect the rate of scratch wound
closure, those cells at the leading edge of the scratch
margins would be required to undergo repeated doublings,
and this is unlikely to have had a major influence on scratch
wound closure over the time course of these studies.
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Table 1: EXTRACELLULAR MATRIX PROTEINS DETECTED IN MSC
CONDITIONED MEDIUM USING (MALDI-TOF/TOF) MASS SPECTROMETRY
MSC-CM 1 MSC-CM 2 MSC-CM 3
Fibronectin Fibronectin Fibronectin
Type I Collagen Type I Collagen Type I Collagen
Type VI Collagen Type VI Collagen Type VI Collagen
Laminin - -
COMP COMP
Lumican Lumican Lumican
- Decorin -
- HSPG -
SPARC SPARC -
IGFBP-1 - -
Mass spectrometry of MSC-CM from 3 separate donors. MALDI-TOF/TOF mass spectrometry of MSC-CM detected variable protein
content between media conditioned by MSC from three different patient donors.
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Mass spectrometry of MSC-CM revealed numerous factors
(including fibronectin and collagen) in medium conditioned by
each of the three MSC examined and some, including
laminin and decorin, in one or two but not all three of the
MSC-CM samples. Of these ECM components, fibronectin,
collagen and laminin are known to promote or support
angiogenesis[16]. Unusually, in these experiments collagen
did not seem to induce any observable cell response when
compared to decorin. This result may be elucidated through
further study. Fibronectin and collagen contain protein motifs
are known to mediate angiogenesis by integrin receptor
signaling in vivo and in vitro[17-19]. Laminin peptides have also
been shown to be pro-angiogenic[20]. Conversely decorin and
lumican have been shown to inhibit angiogenesis. Decorin
inhibits endothelial cell migration and tubule formation in vitro[21] and inhibits the pro-angiogenic effects of VEGF[22].
Lumican interferes with α2β1 receptor activity and inhibits
angiogenesis both in vitro and in vivo[23, 24]. Whilst lumican
was present in each of the MSC-CM used in these
investigations, decorin was only found within the MSC-CM
that consistently showed significantly less enhancement of
EaHy-926 endothelial cell migration. As the method (MALDI-
TOF/TOF mass spectrometry) used to detect these protein
components within MSC-CM was not quantitative, it was not
possible to determine whether differences in concentrations
of each ECM component were related to efficacy of the
conditioned media.
MSC-CM coating of culture plates enhanced EaHy-926
endothelial cell adherence, as did coating with fibronectin.
Cell adherence to these substrata was examined in an
indirect fashion, by assessing the average area of cells in the
immediate-early period after seeding. As cells settle upon a
permissive substrate they spread out from the rounded
morphology observed in suspension to adopt a flattened
morphology that is usually seen in vitro in adherent cell
populations. After prolonged periods of time, cells in culture,
including endothelial cells, synthesize matrix molecules that
may also promote cell adhesion, potentially masking the
initial effects of the original substrate being investigated. Of
the matrix proteins detected in MSC-CM by MALDI-TOF/TOF
mass spectrometry, fibronectin was observed to have a
profound effect upon cell adherence, similar to those findings
concerning cell migration.
Individually, fibronectin appears contribute to the MSC-CM
effects observed. However, the addition of MSC-CM to
endothelial cell scratch assays performed upon fibronectin
coated culture plates resulted in a further enhancement of
endothelial cell migration, suggesting that fibronectin may not
be solely responsible for the entire effect. Further
experiments investigating the effects of MSC secreted growth
factors and cytokines individually, and in combination, may
reveal their relative contribution to the enhancement of
endothelial cell migration. The relatively low number of
individual donors examined during this study is a clear
limitation, and although the results presented support the
conclusions that (i) MSC donor variation and secretome
composition may account for differential effects of MSCs on
endothelial cells, and (ii) that this variation should be taken
into consideration in MSC-based regenerative medicine,
subsequent investigation of greater numbers of samples is
required to further authenticate these findings.
Conclusion
Angiogenesis depends on endothelial cell migration and the
actions of endothelial cell chemotactic factors, e.g. VEGF
and IL-8[25-26], and ECM proteins such as collagens,
fibronectin and laminin[15]. Many of these pro-angiogenic
factors have been found to be present within the MSC
secretome both within this investigation and in previous
studies[5]. These experiments have showed that MSC-CM
enhances both the rate of endothelial cell migration and the
adherence of these cells to their culture surface, and that this
effect was, in part, mediated by the presence of fibronectin.
Other studies have also highlighted a role for fibronectin in
stimulating angiogenesis[16, 17]. The effects of MSC-CM upon
endothelial cell migration were not entirely induced by
fibronectin, as suggested by the further enhancement of
EaHy-926 endothelial cell migration by MSC-CM in the
presence of exogenous fibronectin. Factors such as
Interleukin (IL)-8, VEGF, and laminin have all been shown to
be stimulatory to endothelial cells[19, 24] and these factors
have been shown to be present within MSC-CM[7]. It seems
likely that these known mediators of angiogenesis might
contribute to the effects of MSC-CM upon EaHy926
endothelial cells observed in these investigations.
Overall, the data presented here support the hypothesis that
MSC may stimulate the formation of new vasculature, and
that this may be an important aspect of MSC-mediated
enhancement of wound healing.
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CD: Cluster of Differentiation
COMP: Cartilage Oligomeric Matrix Protein
DMEM: Dulbecco’s modiﬁed Eagle's Medium
ECM: Extracellular Matrix
FCS: Fetal Calf Serum
HSPG: Heparan Sulphate Proteoglycan
IGFBP: Insulin-like Growth Factor Binding Protein
IL: Interleukin
ISCT: International Society for Cellular Therapy
MALDI-TOF/TOF: Matrix-Assisted Laser Desorption/Ionization-Time Of Flight/Time Of Flight
MSC: Mesenchymal Stem Cell
MSC-CM: Mesenchymal Stem Cell-Conditioned Medium
PBS: Phosphate Buffered Saline
SEM: Standard Error of the Mean
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VEGF: Vascular Endothelial Growth Factor
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